Immix Biopharma, Inc. (IMMX) — Stock Score Summary

Immix Biopharma, Inc. (IMMX) has a MoatMap StockRank of 52/100 based on Quality (38/100), Value (36/100), and Momentum (64/100) factor scores. The current signal is HOLD. Immix Biopharma is a micro-cap clinical-stage biotechnology company. It is highly speculative, lacks positive cash flows, and does not possess the validated, high-utilization manufacturing assets required to play the CDMO theme.

Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing novel anti-cancer therapies based on its proprietary SMARxT Tissue-Specific™ Platform. The company focuses on developing tissue-specific therapeutics designed to enhance efficacy and reduce side effects by concentrating drugs in tumor tissues. Its innovative approach aims to address high unmet medical needs in oncology, differentiating it within the competitive cancer therapy landscape.

Key Financial Metrics

Price$8.01
Market Cap$629M
P/E (Forward)-13.00
Price/Book5.29
Return on Equity-74.5%
Return on Invested Capital-31.6%
Debt/Equity1.23
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-20M

Immix Biopharma, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Immix Biopharma, Inc.’s (IMMX) StockRank?
MoatMap’s StockRank for Immix Biopharma, Inc. (IMMX) is 52/100, with a Hold signal. It is a composite of Quality (38), Value (36), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does Immix Biopharma, Inc. have an economic moat?
Immix Biopharma, Inc. (IMMX) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Immix Biopharma, Inc. a buy, hold, or sell?
MoatMap’s current signal for Immix Biopharma, Inc. (IMMX) is Hold, based on a StockRank of 52/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Immix Biopharma, Inc. in?
Immix Biopharma, Inc. (IMMX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksIMMX deep dive reportAI ChampionsHow we score stocksSense-check another stock